Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Exclusive-Activist investor Elliott targets drugmaker BioMarin -sources
By Svea Herbst-Bayliss NEW YORK (Reuters) - Activist investor Elliott Investment Management has built a stake in BioMarin Pharmaceutical and has been in discussions with the biotechnology company for ...
Nov 07, 2023
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
(Reuters) - Biogen and Sage Therapeutics' oral pill to treat postpartum depression (PPD) in adults is expected to cost U.S. wholesalers $15,900 for a full 14-day treatment, Sage Therapeutics said on T...
Nov 07, 2023
Novo Nordisk to present new data from weight-loss, diabetes trials
COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it will present new cardiometabolic disease data, including results from its SELECT trial, at the annual American Heart Association ...
Nov 07, 2023
Johnson & Johnson to submit application to start trials for its robotic surgical system
(Reuters) - Johnson & Johnson MedTech unit said on Tuesday it would submit an application to the U.S. Food & Drug Administration in the second half of 2024 to initiate clinical trials of its robotic s...
Nov 07, 2023
Zimmer Biomet beats quarterly profit estimates on knee procedure strength
(Reuters) - Zimmer Biomet Holdings Inc on Tuesday beat Wall Street estimates for third-quarter profit, as a rebound in knee surgeries lifted demand for the medical device maker's products. On an adjus...
Nov 07, 2023
Italy’s Recordati sees 2023 results at top end of the range
(Reuters) -Italian drugmaker Recordati expects its 2023 results to land at the high-end of previously indicated ranges as it reported double-digit growth in revenue and net profit in the first nine mo...
Nov 07, 2023
India’s Alembic Pharma Q2 profit roughly in-line with estimates
BENGALURU (Reuters) - India's Alembic Pharmaceuticals on Tuesday reported second-quarter profit roughly in line with estimates, as higher sales in its domestic and overseas markets offset a jump in ex...
Nov 07, 2023
WuXi Biologics’ medical research unit eyes up to $471 million in Hong Kong IPO
(Reuters) -China-headquartered WuXi XDC, the contract medical researching unit of WuXi Biologics (Cayman), said on Tuesday it intended to raise up to HK$3.68 billion ($470.56 million) in one of Hong K...
Nov 06, 2023
Vertex Pharma misses sales estimates on weak demand for older CF treatments
(Reuters) - Vertex Pharmaceuticals missed Wall Street estimates for third-quarter sales on Monday, hurt by weaker-than-expected demand for its older cystic fibrosis (CF) treatments. The drugmaker reco...
Nov 06, 2023
Judge trims US lawsuit accusing Cencora of fueling opioid epidemic
By Brendan Pierson (Reuters) - A federal judge on Monday pared back a U.S. government lawsuit accusing drug distributor Cencora, formerly called AmerisourceBergen, of fueling the nation's deadly opioi...
Nov 06, 2023
